What Democrats’ Drug Pricing Plan Means for Consumers
The new drug pricing plan creates protections against out-of-pocket costs for seniors with Medicare Part D benefits and people who take insulin.

The new drug pricing plan creates protections against out-of-pocket costs for seniors with Medicare Part D benefits and people who take insulin.

The Third Circuit Court of Appeals’ ruling avoids extending a federal statute limiting pandemic liability into unprecedented areas.

Most seniors and their loved ones don’t realize the barriers that make aging in place a difficult proposition until a crisis occurs.

While the proposed expansion has met pushback, including these aspects of health care in standard insurance plans is significantly overdue.

The doctrine of capacity is vague, normatively and medically challenging, and inconsistently applied.

FDA’s approval of aducanumab may run against the bioethical principles of beneficence and non-maleficence.

Patients are understandably desperate, but their needs are best served by following the science, rather than lowering the standards for drugs.

There are a series of practical reforms that could readily improve the quality of nursing home care.

Family caregivers hold a critical role in the health care system and the economy, but do not receive adequate support and recognition.
